中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
22期
15-15,16
,共2页
美沙拉嗪%培菲康%溃疡性结肠炎%临床疗效
美沙拉嗪%培菲康%潰瘍性結腸炎%臨床療效
미사랍진%배비강%궤양성결장염%림상료효
Mesalazine triazine%Bifico%Ulcerative colitis%Clinical efficacy
目的探讨美沙拉嗪联合培菲康治疗溃疡性结肠炎的临床疗效。方法选取我院2005年~2012年80例溃疡性结肠炎患者的资料，根据其治疗方式分为观察组和治疗组，各40例，两组均应用美沙拉嗪治疗，观察组患者加用培菲康，随访8周，对两组患者治疗效果进行评价。结果观察组患者治疗效果好，与对照组患者比较差异有统计学意义（P＜0.05）。结论美沙拉嗪联合培菲康治疗溃疡性结肠炎，能降低炎性反应，提高治疗效果，值得在临床推广。
目的探討美沙拉嗪聯閤培菲康治療潰瘍性結腸炎的臨床療效。方法選取我院2005年~2012年80例潰瘍性結腸炎患者的資料，根據其治療方式分為觀察組和治療組，各40例，兩組均應用美沙拉嗪治療，觀察組患者加用培菲康，隨訪8週，對兩組患者治療效果進行評價。結果觀察組患者治療效果好，與對照組患者比較差異有統計學意義（P＜0.05）。結論美沙拉嗪聯閤培菲康治療潰瘍性結腸炎，能降低炎性反應，提高治療效果，值得在臨床推廣。
목적탐토미사랍진연합배비강치료궤양성결장염적림상료효。방법선취아원2005년~2012년80례궤양성결장염환자적자료，근거기치료방식분위관찰조화치료조，각40례，량조균응용미사랍진치료，관찰조환자가용배비강，수방8주，대량조환자치료효과진행평개。결과관찰조환자치료효과호，여대조조환자비교차이유통계학의의（P＜0.05）。결론미사랍진연합배비강치료궤양성결장염，능강저염성반응，제고치료효과，치득재림상추엄。
Objective To investigate the clinical efficacy the of Mesalazine joint Bifico the treatment of ulcerative colitis. Methods Our hospital from 2005 to 2012, 80 patients with ulcerative colitis patients, divided into observation group and a treatment group based on their treatment, 40 patients in both groups applied mesalazine treatment, patients of the observation group and with Bifico followed for 8 weeks to evaluate the therapeutic effect of two groups of patients. Results The patient outcomes compared with the control group of patients was statistically significant (P<0.05) difference. Conclusion The of mesalazine joint Bifico the treatment of ulcerative colitis, can reduce the inflammatory response, improve treatment, worth in clinical practice.
